Guild showcases future of women’s services
THE Pharmacy Guild of Australia has partnered with Sexual Health and Reproductive Health Australia to showcase the future of women’s…
Wesfarmers Health FY25 earnings up 28%
WESFARMERS released its 2025 full-year results this morning, reporting a net profit after tax of $2.9 billion for the group.…
Forest lung steam inhaler
INSPIRED by traditional steam inhalation remedies, Australian skincare brand Etto has launched Forest Lungs Steam Inhalers to help soothe colds…
Editor’s Choice: LOoPHA offers science-backed scented skincare
LOOPHA is a bodycare range from Canadian skincare giant Deciem that combines high-performing formulations and science-backed active skincare with fresh…
AdPha stands with NT hospital pharmacists on industrial action
WORKFORCE shortages putting patient care at risk in the Northern Territory must be urgently addressed, Advanced Pharmacy Australia (AdPha) said.…
Vape dependence tool gets TGA tick
THE Therapeutic Goods Administration (TGA) has approved Nicorette QuickMist oral spray for the treatment of nicotine vaping dependence, becoming the…
GST on painkillers up for review
THE Department of Health, Disability and Ageing is seeking comment on a proposal to maintain the GST-free status on small…
GBMA appoints Teva’s Dr Stephen Jenkins to Board of Directors
THE Generic and Biosimilar Medicines Association (GBMA) has appointed Dr Stephen Jenkins, Director of Government and Corporate Affairs APAC at…
One week to go
WITH the highly anticipated Pharmacy Connect 2025 conference kicking off next week, book now for the latest industry updates, fresh…
Oral SERDs in Breast Cancer: Imulnestrant and Elacestrant
Oral selective estrogen receptor degraders (SERDs) are a promising line of treatments for patients with breast cancer.